KASL clinical practice guidelines: management of hepatitis C
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Sook-Hyang | - |
dc.contributor.author | Lee, Jung Il | - |
dc.contributor.author | Kim, Young Seok | - |
dc.contributor.author | Kim, Kyung-Ah | - |
dc.contributor.author | Park, Sang Hoon | - |
dc.contributor.author | Lee, Byung Seok | - |
dc.contributor.author | Park, Jun Yong | - |
dc.contributor.author | Yoon, Ki Tae | - |
dc.contributor.author | Jung, Young Kul | - |
dc.contributor.author | Kim, Chang Wook | - |
dc.contributor.author | Cho, Eun Young | - |
dc.contributor.author | Gwak, Geum-Youn | - |
dc.contributor.author | Chung, Woo Jin | - |
dc.contributor.author | Kim, Jeong Han | - |
dc.date.accessioned | 2021-09-04T02:22:22Z | - |
dc.date.available | 2021-09-04T02:22:22Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-03 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89451 | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC STUDY LIVER | - |
dc.subject | SUSTAINED VIROLOGICAL RESPONSE | - |
dc.subject | HUMAN-IMMUNODEFICIENCY-VIRUS | - |
dc.subject | SOFOSBUVIR PLUS RIBAVIRIN | - |
dc.subject | PEGYLATED INTERFERON-ALPHA | - |
dc.subject | GENOTYPE 1 INFECTION | - |
dc.subject | TREATMENT-NAIVE PATIENTS | - |
dc.subject | CHRONIC VIRAL-HEPATITIS | - |
dc.subject | HEPATOCELLULAR-CARCINOMA DEVELOPMENT | - |
dc.subject | DIRECT-ACTING ANTIVIRALS | - |
dc.subject | TRANSFUSION-ASSOCIATED HEPATITIS | - |
dc.title | KASL clinical practice guidelines: management of hepatitis C | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Young Kul | - |
dc.identifier.doi | 10.3350/cmh.2016.22.1.76 | - |
dc.identifier.wosid | 000407830900004 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, v.22, no.1, pp.76 - 139 | - |
dc.relation.isPartOf | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.title | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.volume | 22 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 76 | - |
dc.citation.endPage | 139 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | SUSTAINED VIROLOGICAL RESPONSE | - |
dc.subject.keywordPlus | HUMAN-IMMUNODEFICIENCY-VIRUS | - |
dc.subject.keywordPlus | SOFOSBUVIR PLUS RIBAVIRIN | - |
dc.subject.keywordPlus | PEGYLATED INTERFERON-ALPHA | - |
dc.subject.keywordPlus | GENOTYPE 1 INFECTION | - |
dc.subject.keywordPlus | TREATMENT-NAIVE PATIENTS | - |
dc.subject.keywordPlus | CHRONIC VIRAL-HEPATITIS | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA DEVELOPMENT | - |
dc.subject.keywordPlus | DIRECT-ACTING ANTIVIRALS | - |
dc.subject.keywordPlus | TRANSFUSION-ASSOCIATED HEPATITIS | - |
dc.subject.keywordAuthor | Hepatitis C | - |
dc.subject.keywordAuthor | Management | - |
dc.subject.keywordAuthor | Guidelines | - |
dc.subject.keywordAuthor | KASL | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.